Physician profile
Benjamin Jenny
NPI 1629413828
$66,100.45
in general payments reported to CMS, 2019-2025
25 companies · $16K in 2025
The $16K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,283 · 2020: $6,897 · 2021: $1,376 · 2022: $10K · 2023: $14K · 2024: $12K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26K · Travel and Lodging: $8,424 · Consulting Fee: $7,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25,923.50 |
| Travel and Lodging | $8,424.42 |
| Consulting Fee | $7,154.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16,297.69 | 2019-2025 | Watchman Flx, Watchman Access System, Versacross Steerable Access Solution |
| Abbott Laboratories | $14,853.63 | 2020-2025 | Aveir, Ensite Precision, Na |
| Biosense Webster, INC. | $10,233.30 | 2022-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Impulse Dynamics (USA) INC. | $6,645.05 | 2023-2025 | Optimizer, Optimizer |
| Cardiva Medical, INC. | $4,168.54 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Teg6s Hemostasis System, Teg5000 Hemostasis Analyzer |
| Biotronik INC. | $2,926.87 | 2022-2024 | Acticor 7 Vr-T Dx |
| Atricure, INC. | $2,902.97 | 2023-2025 | Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $2,410.65 | 2019-2020 | |
| Medtronic, INC. | $1,885.07 | 2022-2025 | Crome Dr Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Medical Device Business Services, INC. | $1,090.90 | 2024 | Carto 3 |
| Kestra Medical Technology Services, INC. | $558.83 | 2024-2025 | Assure Wcd |
| Cordis US Corp. | $469.52 | 2025 | Mynx Control Venous, Mynx Control |
| Pfizer INC. | $302.47 | 2019-2021 | |
| Abiomed | $291.62 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.61 | 2024-2025 | Lifevest |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $238.75 | 2019-2022 | |
| Astellas Pharma US INC | $175.43 | 2019-2021 | |
| Arineta, INC | $128.28 | 2023 | Cardiographe |
| Heartflow, INC. | $76.45 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $58.81 | 2022 | |
| Amgen INC. | $51.24 | 2020-2021 | |
| Haemonetics Corporation | $22.34 | 2024 | Ensoetm |
| Cvrx, INC. | $22.09 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $13.53 | 2019 | |
| Baylis Medical Company INC | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jenny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.